ENROXIL MAX 100 MG/ML SOLUTION FOR INJECTION FOR CATTLE

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

ENROFLOXACIN

제공처:

Krka, d.d., Novo mesto

ATC 코드:

QJ01MA90

INN (International Name):

ENROFLOXACIN

복용량:

100 Mg/Ml

약제 형태:

Solution for Injection

처방전 유형:

POM

치료 그룹:

Bovine

치료 영역:

Enrofloxacin

치료 징후:

Antibacterial

승인 상태:

Authorised

승인 날짜:

2008-09-19

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Enroxil Max 100 mg/ml solution for injection for cattle.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
3 PHARMACEUTICAL FORM
Solution for injection.
Clear, yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of bovine respiratory disease associated with _Mannheimia haemolytica_, _Pasteurella multocida_, _Histophilus_
_somni _and _Mycoplasma _spp. where clinical experience, supported where possible by sensitivity testing of the causal
organism, indicates enrofloxacin as the drug of choice.
Treatment of local signs (inflammation, milk quality and yield) associated with peracute/acute mastitis in lactating
dairy cattle caused by _E. coli_, where herd history and previous sensitivity testing indicate enrofloxacin as the drug of
choice.
4.3 CONTRAINDICATIONS
Do not use for prophylaxis.
Do not administer in case of hypersensitivity to the active substance or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
ACTIVE SUBSTANCE
Enrofloxacin
100 mg
EXCIPIENTS
Benzyl alcohol (E1519)
20 mg
Butyl alcohol
30 mg
For a full list of excipients, see section 6.1
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 28/05/2015_
_CRN 7020775_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Normal sterile precautions should be taken.
The safety of the product has not been established in calves when administered by the intravenous route and use of this
route of administration in calves is therefore not recommended.
Official and local antimicrobial policies should be taken into account w